This compound is a chiral pharmaceutical intermediate featuring both an epoxide ring and a nitrobenzenesulfonate ester group. Its primary significance lies in its use as a synthetic building block for the preparation of enantiomerically pure pharmaceutical compounds.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 115314-17-5
(S)-(+)-Glycidyl-4-nitrobenzoate
Chiral building block for synthesis
(R)-(-)-Glycidyl-4-nitrobenzenesulfonate
chiral intermediate for active pharmaceutical ingredients
[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
pharmaceutical intermediate
(2-BOC-AMINOPHENYL)BORONIC ACID
Pharmaceutical intermediate for boronic acid synthesis
1-(tert-Butoxycarbonyl)-3-(cyanomethylene)azetidine
pharmaceutical research intermediate
2H,4H,5H,6H,7H,7aH-thieno[3,2-c]pyridin-2-one hydrochloride
pharmaceutical intermediate
Glycidyl 3-nitrobenzenesulfonate
Pharmaceutical intermediate
(2R)-(-)-Glycidyl tosylate
Pharmaceutical intermediate for chiral synthesis
[(2R)-oxiran-2-yl]methyl 3-nitrobenzenesulfonate
AIHIHVZYAAMDPM-MRVPVSSYSA-N
C1[C@@H](O1)COS(=O)(=O)C2=CC=CC(=C2)[N+](=O)[O-]